Hyderabad: Dr Reddy`s Laboratories on Monday announced that it has launched Amlodipine Benazepril capsules, a bio-equivalent generic version of Lotrel Capsules, in the US market.
In September 2009, Dr Reddy’s entered into a patent settlement with Novartis on Amlodipine Benazepril stipulating the dismissal of the lawsuits in the United States.
The United States Food & Drug Administration (USFDA) granted approval for Dr Reddy`s ANDA for Amlodipine Benazepril on April 15 and subsequently the drug was launched last week.
Amlodipine Benazepril is used for the treatment of hypertension in patients not adequately controlled with either agent and is taken once daily. The product is available
in bottles of 100 count capsules.
Bureau Report